Phase II trial of RO269228
Latest Information Update: 19 Apr 2022
At a glance
- Drugs Elocalcitol (Primary)
- Indications Osteoporosis
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 19 Apr 2022 New trial record
Latest Information Update: 19 Apr 2022